Clinical Trial Update: Efficacy and Safety of Isosorbide Oral Solution in Patients With Meniere's Disease [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports a Phase 2/3 study evaluating an isosorbide oral solution for Menière's disease. The study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menière Disease

Drugs mentioned

• Isosorbide Oral Solution (isosorbide)

Snippet

Sponsor: Lunan Better Pharmaceutical Co., LTD. | Conditions: Meniere´s Disease | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING